The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

Citations

Citations to this article as recorded by  

• Serum-based ATR-FTIR spectroscopy combined with multivariate analysis for the diagnosis of pre-diabetes and diabetes
  Weiyi Pang, Yu Xing, Camilo L. M. Morais, Qiufeng Lao, Shengle Li, Zipeng Qiao, You Li, Maneesh N. Singh, Valério G. Barauna, Francis L. Martin, Zhiyong Zhang
  The Analyst.2024; 149(2): 497.     CrossRef
• Fruits and the Risk of Type 2 Diabetes: The Korean Genome and Epidemiology Study Cohort
  Hojun Yu, Cheol Min Lee, Seung-Won Oh
  Korean Journal of Family Medicine.2024; 45(1): 44.     CrossRef
• Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus
  Yesol Hong, Yoomin Jeon, Yoona Choi, Tae Kyu Chung, Howard Lee
  Diabetes Therapy.2024; 15(2): 487.     CrossRef
• Risk factors for carotid plaque formation in type 2 diabetes mellitus
  Jin Chen, Wenwen Li, Jingzhu Cao, Yuhan Lu, Chaoqun Wang, Jin Lu
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Cumulative exposure to impaired fasting glucose and gastrointestinal cancer risk: A nationwide cohort study
  Byeong Yun Ahn, Bokyung Kim, Sanghyun Park, Sang Gyun Kim, Kyungdo Han, Soo‐Jeong Cho
  Cancer.2024;[Epub]     CrossRef
• Effects of a Health Partnership Program Using Mobile Health Application for Male Workers with Cardiovascular Risk Factors in Small and Medium Enterprises: A Randomized Controlled Trial
  Eun Jin Kim, Seon Young Hwang
  Journal of Korean Academy of Nursing.2024; 54(1): 44.     CrossRef
• The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population
  Na Yeon Kim, Haekyung Lee, Sehee Kim, Ye-Jee Kim, Hyunsuk Lee, Junhyeong Lee, Soo Heon Kwak, Seunggeun Lee
  Scientific Reports.2024;[Epub]     CrossRef
• Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
  Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
  Advances in Therapy.2024;[Epub]     CrossRef
• The Potential Role of Presepsin in Predicting Severe Infection in Patients with Diabetic Foot Ulcers
  Eun Yeong Ha, Il Rae Park, Seung Min Chung, Young Nam Roh, Chul Hyun Park, Tae-Gon Kim, Woong Kim, Jun Sung Moon
  Journal of Clinical Medicine.2024; 13(8): 2311.     CrossRef
• Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
  Jaime A Davidson, Norlela Sukor, Fen‐Lee Hew, Mafauzy Mohamed, Zanariah Hussein
  Journal of Diabetes Investigation.2023; 14(2): 167.     CrossRef
• β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months
  Minyoung Lee, Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee
  Diabetes & Metabolism.2023; 49(4): 101427.     CrossRef
• Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
  Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
  Journal of Lipid and Atherosclerosis.2023; 12(1): 12.     CrossRef
• Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
  Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
  Diabetes & Metabolism Journal.2023; 47(1): 1.     CrossRef
• Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
  Min Kyong Moon, Junghyun Noh, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong
  Diabetes & Metabolism Journal.2023; 47(1): 45.     CrossRef
• Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
  Sejeong Lee, Jaehyun Bae, Doo Ri Jo, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Identifying the Associations of Nightly Fasting Duration and Meal Timing with Type 2 Diabetes Mellitus Using Data from the 2016–2020 Korea National Health and Nutrition Survey
  Junkyung Kwak, Kyeong-A Jang, Haeng-Ran Kim, Min-Sook Kang, Kyung Won Lee, Dayeon Shin
  Nutrients.2023; 15(6): 1385.     CrossRef
• Development and Adaptability of Smartphone-based Dietary Coaching Program for Patients Undergoing Diabetes and Prediabetes with Continuous Glucose Monitoring Device
  Myoung Soo Kim, Jung Mi Ryu, Minkyeong Kang, Jiwon Park, Yeh Chan Ahn, Yang Seok Kim
  Journal of Health Informatics and Statistics.2023; 48(1): 36.     CrossRef
• Glucose Control in Korean Patients with Type 2 Diabetes Mellitus according to Body Mass Index
  Ye-lim Shin, Heesoh Yoo, Joo Young Hong, Jooeun Kim, Kyung-do Han, Kyu-Na Lee, Yang-Hyun Kim
  Journal of Obesity & Metabolic Syndrome.2023; 32(1): 55.     CrossRef
• Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up
  Ji Young Kang, Kyungdo Han, Seung-Hwan Lee, Mee Kyoung Kim
  Respiratory Research.2023;[Epub]     CrossRef
• Developing a Classification Algorithm for Prediabetes Risk Detection From Home Care Nursing Notes
  Eunjoo Jeon, Aeri Kim, Jisoo Lee, Hyunsook Heo, Hana Lee, Kyungmi Woo
  CIN: Computers, Informatics, Nursing.2023; 41(7): 539.     CrossRef
• Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
  Yun Kyung Cho, Myungjin Kim, Ye-Jee Kim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study
  Gyu Bae Lee, Youn Huh, Sang Hyun Lee, Byoungduck Han, Yang-Hyun Kim, Do-Hoon Kim, Seon Mee Kim, Youn Seon Choi, Kyung Hwan Cho, Ga Eun Nam
  World Journal of Gastroenterology.2023; 29(45): 5962.     CrossRef
• Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes
  Han Na Jang, Ye Seul Yang, Tae Jung Oh, Bo Kyung Koo, Seong Ok Lee, Kyong Soo Park, Hak Chul Jang, Hye Seung Jung
  Journal of Diabetes Investigation.2022; 13(1): 85.     CrossRef
• Relationship between the early initiation of insulin treatment and diabetic complications in patients newly diagnosed with type 2 diabetes mellitus in Korea: A nationwide cohort study
  Ha‐Lim Jeon, Won Kim, Bongseong Kim, Ju‐Young Shin
  Journal of Diabetes Investigation.2022; 13(5): 830.     CrossRef
• Relationship of the Triglyceride-Glucose Index with Subclinical White Matter Hypersensitivities of Presumed Vascular Origin Among Community-Dwelling Koreans
  Dong-Hyuk Jung, Byoungjin Park, Yong-Jae Lee
  International Journal of General Medicine.2022; Volume 15: 603.     CrossRef
• Prevalence of vitamin B12 deficiency and its association with metformin-treated type 2 diabetic patients: A cross sectional study
  Shaimaa B. Almatrafi, El-Sayed H. Bakr, Asem A. Almatrafi, Manal M. Altayeb
  Human Nutrition & Metabolism.2022; 27: 200138.     CrossRef
• Retinal Vascular Caliber Changes in Early Type 2 Diabetic Patients without Retinopathy
  Jeong Woo Park, Jeong Hun Bae, Su Jeong Song, Joon Mo Kim
  Journal of the Korean Ophthalmological Society.2022; 63(1): 20.     CrossRef
• Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
  Hae Kyung Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Diabetes & Metabolism Journal.2022; 46(1): 104.     CrossRef
• Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
  Jae Hyun Bae, Chang Ho Ahn, Ye Seul Yang, Sun Joon Moon, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park, Young Min Cho
  Diabetes & Metabolism Journal.2022; 46(1): 71.     CrossRef
• Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition
  Dong Yoon Kang, Hyunah Kim, SooJeong Ko, HyungMin Kim, Jiwon Shinn, Min-Gyu Kang, Sun-ju Byeon, Jeong-Hee Choi, Soo-Yong Shin, Hun-Sung Kim
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus
  Ji Eun Han, Han-Bit Shin, Young Hwan Ahn, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun Kim
  Scientific Reports.2022;[Epub]     CrossRef
• Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
  Viswanathan Mohan, Banshi Saboo, Jabbar Khader, Kirtikumar D Modi, Sushil Jindal, Subhash Kumar Wangnoo, Sugumaran Amarnath
  Clinical Medicine Insights: Endocrinology and Diabetes.2022; 15: 117955142210746.     CrossRef
• Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model
  Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Sang Soo Kim, Eun-Hee Cho, Tae Sun Park
  Medicine.2022; 101(8): e28823.     CrossRef
• Atherogenic Index of Plasma and Its Association with Risk Factors of Coronary Artery Disease and Nutrient Intake in Korean Adult Men: The 2013–2014 KNHANES
  Hye Ran Shin, SuJin Song, Jin Ah Cho, Sun Yung Ly
  Nutrients.2022; 14(5): 1071.     CrossRef
• Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
  Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi
  Journal of Diabetes Investigation.2022; 13(6): 986.     CrossRef
• Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
  Liela Meng, Keun-Sang Kwon, Dae Jung Kim, Yong-ho Lee, Jeehyoung Kim, Abhijit V. Kshirsagar, Heejung Bang
  Diabetes & Metabolism Journal.2022; 46(2): 273.     CrossRef
• Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery
  Yeyoung Han, Gihyeon Kim, Eunyong Ahn, Sunhee Jung, Youngae Jung, Yunjae Kim, Eunyoung Ha, Yoonseok Heo, Do Hyun Ryu, Hansoo Park, Geum‐Sook Hwang
  Diabetes, Obesity and Metabolism.2022; 24(7): 1224.     CrossRef
• The use of complex marketing analysis and QSPR methodology for the necessity of a drug development grounding for the treatment of type 2 diabetes mellitus with increased bioavailability
  Inna Kovalevska, Olena Ruban, Alina Volkova, Alla Kotvitska, Alina Cherkashyna
  Pharmacia.2022; 69(2): 303.     CrossRef
• Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
  Sangmo Hong, Woo Je Lee, Cheol-Young Park
  Endocrinology and Metabolism.2022; 37(2): 233.     CrossRef
• Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients
  Won Seok Kim, Yonghoon Choi, Nayoung Kim, Seon Hee Lim, Gitark Noh, Ki Wook Kim, Jaehyung Park, Hyeongho Jo, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
  The Korean Journal of Internal Medicine.2022; 37(3): 579.     CrossRef
• Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
  Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
  Dae-Sung Kyoung, Hun-Sung Kim
  Journal of Lipid and Atherosclerosis.2022; 11(2): 103.     CrossRef
• Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study
  Si Hyoung Kim, Yun Kyung Cho, Ye-Jee Kim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park, Ji Hye Huh, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
  Cardiovascular Diabetology.2022;[Epub]     CrossRef
• Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
  Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sung
  Diabetes & Metabolism Journal.2022; 46(3): 464.     CrossRef
• Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
  Jaehyun Bae, Young-eun Kim, Minyoung Lee, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Yonsei Medical Journal.2022; 63(6): 539.     CrossRef
• Predictors for successful weight reduction during treatment with Dapagliflozin among patients with type 2 diabetes mellitus in primary care
  Youn Huh, Young Sik Kim
  BMC Primary Care.2022;[Epub]     CrossRef
• Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
  Xiao-Ying Li, Li Li, Sang-Hoon Na, Francesca Santilli, Zhongwei Shi, Michael Blaha
  American Journal of Preventive Cardiology.2022; 11: 100363.     CrossRef
• Factors Influencing the Utilization of Diabetes Complication Tests Under the COVID-19 Pandemic: Machine Learning Approach
  Haewon Byeon
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes
  Mee Kyoung Kim, Kyungdo Han, Bongsung Kim, Jinyoung Kim, Hyuk-Sang Kwon
  Scientific Reports.2022;[Epub]     CrossRef
• Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
  Endocrinology and Metabolism.2022; 37(3): 466.     CrossRef
• Analysis of Continuity of Care and Its Related Factors in Diabetic Patients: A Cross-Sectional Study
  Ji Yeh Shin, Ha Jin Kim, BeLong Cho, Yun Jun Yang, Jae Moon Yun
  Korean Journal of Family Medicine.2022; 43(4): 246.     CrossRef
• Development of Various Diabetes Prediction Models Using Machine Learning Techniques
  Juyoung Shin, Jaewon Kim, Chanjung Lee, Joon Young Yoon, Seyeon Kim, Seungjae Song, Hun-Sung Kim
  Diabetes & Metabolism Journal.2022; 46(4): 650.     CrossRef
• A causal relationship between alcohol intake and type 2 diabetes mellitus: A two-sample Mendelian randomization study
  Meiling Liu, Sunmin Park
  Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(12): 2865.     CrossRef
• Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia
  Seong Ho Kim, Ji Young Kim, Eun Song Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Annals of Medicine.2022; 54(1): 2724.     CrossRef
• Association of the Estimated Pulse Wave Velocity with Cardio-Vascular Disease Outcomes among Men and Women Aged 40–69 Years in the Korean Population: An 18-Year Follow-Up Report on the Ansung–Ansan Cohort in the Korean Genome Environment Study
  Byung Sik Kim, Yonggu Lee, Jin-Kyu Park, Young-Hyo Lim, Jeong-Hun Shin
  Journal of Personalized Medicine.2022; 12(10): 1611.     CrossRef
• Perfluorinated compounds in adults and their association with fasting glucose and incident diabetes: a prospective cohort study
  Seung Min Chung, Dong-Gyu Heo, Ju-Hyun Kim, Ji Sung Yoon, Hyoung Woo Lee, Jong-Yeon Kim, Jun Sung Moon, Kyu Chang Won
  Environmental Health.2022;[Epub]     CrossRef
• Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
  Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
  Frontiers in Public Health.2022;[Epub]     CrossRef
• Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness
  Juyoung Shin, Joonyub Lee, Taehoon Ko, Kanghyuck Lee, Yera Choi, Hun-Sung Kim
  Journal of Personalized Medicine.2022; 12(11): 1899.     CrossRef
• Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?
  Jeongmin Lee, Min-Hee Kim, Jung-Min Lee, Sang-Ah Chang
  Journal of Clinical Medicine.2022; 11(22): 6756.     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors
  Jianhua Ma, Bin Zhang, Jianing Hou, Yongde Peng
  Diabetes Therapy.2021; 12(1): 211.     CrossRef
• Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: AnEast Asianperspective
  Linong Ji, Juliana C. N. Chan, Miao Yu, Kun Ho Yoon, Sin Gon Kim, Sung Hee Choi, Chien‐Ning Huang, Shih Te Tu, Chih‐Yuan Wang, Päivi Maria Paldánius, Wayne H. H. Sheu
  Diabetes, Obesity and Metabolism.2021; 23(1): 3.     CrossRef
• Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study
  Seung Jin Han, Kyoung Hwa Ha, Nami Lee, Dae Jung Kim
  Diabetes, Obesity and Metabolism.2021; 23(3): 682.     CrossRef
• Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an International Expert Group (South Asia, Middle East & Africa) via modified Delphi method
  Sanjay Kalra, Das A. K., Fariduddin Md., Shaikh K., Shah P., Rehim A. A., John M., Shaikh S., Orabi A., Saraswati M. R., Shahjada Selim, Baruah M. P., K. K. Gangopadhyay, Langi Y. A., Nair T., Dhanwal D., Thapa S. D., Deshmukh V., D. Dutta, Khalfan H., Ma
  Current Medical Research and Opinion.2021; 37(3): 403.     CrossRef
• The association between lipoprotein (a) and carotid atherosclerosis in patients with type 2 diabetes without pre-existing cardiovascular disease: A cross-sectional study
  Ji Eun Jun, Hongsun Kang, You-Cheol Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, In-Kyung Jeong
  Diabetes Research and Clinical Practice.2021; 171: 108622.     CrossRef
• Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
  Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef
• Effect of Tai Chi on Quality of Life, Body Mass Index, and Waist-Hip Ratio in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  Jiawei Qin, Yannan Chen, Shuai Guo, Yue You, Ying Xu, Jingsong Wu, Zhizhen Liu, Jia Huang, Lidian Chen, Jing Tao
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
  Soo-Yeon Choi, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2021; 36(2): 263.     CrossRef
• Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
  Chan-Hee Jung, Jang Won Son, Shinae Kang, Won Jun Kim, Hun-Sung Kim, Hae Soon Kim, Mihae Seo, Hye-Jung Shin, Seong-Su Lee, Su Jin Jeong, Yongin Cho, Seung Jin Han, Hyang Mi Jang, Mira Rho, Shinbi Lee, Mihyun Koo, Been Yoo, Jung-Wha Moon, Hye Young Lee, Ja
  Diabetes & Metabolism Journal.2021; 45(1): 1.     CrossRef
• Estimation of sodium‐glucose cotransporter 2 inhibitor–related genital and urinary tract infections via electronic medical record–based common data model
  SooJeong Ko, HyungMin Kim, Jiwon Shinn, Sun‐ju Byeon, Jeong‐Hee Choi, Hun‐Sung Kim
  Journal of Clinical Pharmacy and Therapeutics.2021; 46(4): 975.     CrossRef
• Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study
  Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
  Drug Design, Development and Therapy.2021; Volume 15: 651.     CrossRef
• Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
  Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Hyung-Wook Kim, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko
  Scientific Reports.2021;[Epub]     CrossRef
• Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes
  Han Ul Kim, Sung Pyo Park, Yong-Kyu Kim
  Scientific Reports.2021;[Epub]     CrossRef
• Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
  Jin-Hee Lee, Suk Chon, Seon-Ah Cha, Sun-Young Lim, Kook-Rye Kim, Jae-Seung Yun, Sang Youl Rhee, Kun-Ho Yoon, Yu-Bae Ahn, Jeong-Taek Woo, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2021; 36(2): 382.     CrossRef
• Simple Sugar Intake in Diabetics and Non-Diabetic Patients Who Visit Primary Care Clinic
  Seo Young Park, Geun Bae Moon, Young Sik Kim, Seung Hee Kim
  Korean Journal of Family Practice.2021; 11(1): 29.     CrossRef
• Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
  Da Hea Seo, Kyoung Hwa Ha, So Hun Kim, Dae Jung Kim
  Endocrinology and Metabolism.2021; 36(1): 70.     CrossRef
• Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020
  Eun-Jung Rhee, Mee-Kyung Kim, Won-Young Lee
  Endocrinology and Metabolism.2021; 36(1): 41.     CrossRef
• Factors Associated with Poor Glycemic Control Amongst Rural Residents with Diabetes in Korea
  Junhee Ahn, Youngran Yang
  Healthcare.2021; 9(4): 391.     CrossRef
• Diabetes and Stroke
  Junghyun Noh
  The Journal of Korean Diabetes.2021; 22(1): 26.     CrossRef
• Epidemiology of cardiovascular disease and its risk factors in Korea
  Hyeon Chang Kim
  Global Health & Medicine.2021; 3(3): 134.     CrossRef
• Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus
  Mee Kyoung Kim, Kyungdo Han, Eun Sil Koh, Oak-Kee Hong, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Diabetes Research and Clinical Practice.2021; 175: 108799.     CrossRef
• No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
  Yu Kyong Kim, Jun Gi Hwang, Min Kyu Park
  Drug Design, Development and Therapy.2021; Volume 15: 1725.     CrossRef
• Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Endocrinology and Metabolism.2021; 36(2): 388.     CrossRef
• The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
  Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol-Young Park
  Journal of Alzheimer's Disease.2021; 81(3): 1263.     CrossRef
• Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial
  Eun-Young Lee, Jae-Seung Yun, Seon-Ah Cha, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Seung-Hyun Ko
  International Journal of Environmental Research and Public Health.2021; 18(10): 5300.     CrossRef
• Cerium Oxide Nanoparticle-Containing Colorimetric Contact Lenses for Noninvasively Monitoring Human Tear Glucose
  Sijin Park, Juil Hwang, Hee-Jae Jeon, Woo Ri Bae, In-Kyung Jeong, Tae Gi Kim, Jaheon Kang, Young-Geun Han, Euiheon Chung, Dong Yun Lee
  ACS Applied Nano Materials.2021; 4(5): 5198.     CrossRef
• Low nutritional status links to the prevalence of pre-metabolic syndrome and its cluster in metabolically high-risk Korean adults
  Jieun Kim, Kyoungsik Jeong, Siwoo Lee, Bok-Nam Seo, Younghwa Baek
  Medicine.2021; 100(20): e25905.     CrossRef
• Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status
  Dongsub Jeon, Minkook Son, Juhyun Shim
  Nutrients.2021; 13(5): 1720.     CrossRef
• Classification and Prediction on the Effects of Nutritional Intake on Overweight/Obesity, Dyslipidemia, Hypertension and Type 2 Diabetes Mellitus Using Deep Learning Model: 4–7th Korea National Health and Nutrition Examination Survey
  Hyerim Kim, Dong Hoon Lim, Yoona Kim
  International Journal of Environmental Research and Public Health.2021; 18(11): 5597.     CrossRef
• Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies
  Linong Ji, Yan Bi, Shandong Ye, Yun Huang, Xia Zhang, Shuhua Shang, Nan Cui, Huiqiu Yin, Minlu Zhang
  Diabetes Research and Clinical Practice.2021; 176: 108848.     CrossRef
• Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
  Ahmed Arafa, Hyeok-Hee Lee, Ehab S. Eshak, Kokoro Shirai, Keyang Liu, Jiaqi Li, Naharin Sultana Anni, Sun Young Shim, Hyeon Chang Kim, Hiroyasu Iso
  Korean Circulation Journal.2021; 51(8): 643.     CrossRef
• Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
  Won Euh, Soo Lim, Jin-Wook Kim
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Effect of serum isoniazid level on treatment outcomes among tuberculosis patients with slow response – A retrospective cohort study
  Hyung Woo Kim, Ah Young Shin, Jick Hwan Ha, Joong Hyun Ahn, Hye Seon Kang, Ju Sang Kim
  Journal of Infection and Chemotherapy.2021; 27(11): 1555.     CrossRef
• Recent Perspective of Metformin
  Sangmo Hong
  The Journal of Korean Diabetes.2021; 22(2): 85.     CrossRef
• Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
  Awadhesh K Singh, Ritu Singh, Partha Pratim Chakraborty
  International Journal of General Medicine.2021; Volume 14: 3833.     CrossRef
• The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes
  Jihyun Yoon, Donghyuk Jung, Yongjae Lee, Byoungjin Park
  Journal of Personalized Medicine.2021; 11(8): 742.     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
  Ja Young Jeon
  Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
• 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
  Kyu Yeon Hur, Min Kyong Moon, Jong Suk Park, Soo-Kyung Kim, Seung-Hwan Lee, Jae-Seung Yun, Jong Ha Baek, Junghyun Noh, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Ye Seul Yang, Jang Won Son, Jong Han Choi, Kee Ho Song, Nam Hoon Kim, Sang Yong Kim, Jin Wha Kim,
  Diabetes & Metabolism Journal.2021; 45(4): 461.     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
  Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, Kyeong Jin Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2021; 45(4): 617.     CrossRef
• Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical Data in Korea
  Kyuho Kim, Sung Hee Choi
  Diabetes & Metabolism Journal.2021; 45(4): 502.     CrossRef
• The Effects of Dietary Education Interventions on Individuals with Type 2 Diabetes: A Systematic Review and Meta-Analysis
  Juri Kim, Myung-Haeng Hur
  International Journal of Environmental Research and Public Health.2021; 18(16): 8439.     CrossRef
• Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
  Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
  Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
  Jeonghoon Ha, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Seung Hyun Ko, Moo Il Kang, Sung Dae Moon, Ki-Hyun Baek
  Endocrinology and Metabolism.2021; 36(4): 895.     CrossRef
• Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
  Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
  Endocrinology and Metabolism.2021; 36(4): 823.     CrossRef
• High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study
  Sung-Woo Kim, Jae-Han Jeon, Jun Sung Moon, Mi Kyung Kim
  Endocrinology and Metabolism.2021; 36(4): 800.     CrossRef
• Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans
  Julie J. Kim, Jihyun Yoon, Yong-Jae Lee, Byoungjin Park, Dong-Hyuk Jung
  Nutrients.2021; 13(9): 3231.     CrossRef
• Quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for type 2 diabetes mellitus: A systematic review
  Jeremy Y. Ng, Kiran D. Verma, Kevin Gilotra
  Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(11): 3004.     CrossRef
• Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea
  Hyuk Sang Kwon, Kee Ho Song, Jae Myung Yu, Dong Sun Kim, Ho Sang Shon, Kyu Jeung Ahn, Sung Hee Choi, Seung Hyun Ko, Won Kim, Kyoung Hwa Lee, Il Seong Nam-Goong, Tae Sun Park
  Journal of Obesity & Metabolic Syndrome.2021; 30(3): 261.     CrossRef
• Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes
  Seung-Hwan Lee, Kyungdo Han, Hyuk-Sang Kwon, Mee Kyoung Kim
  Endocrinology and Metabolism.2021; 36(5): 1007.     CrossRef
• How Can We Adopt the Glucose Tolerance Test to Facilitate Predicting Pregnancy Outcome in Gestational Diabetes Mellitus?
  Kyeong Jin Kim, Nam Hoon Kim, Jimi Choi, Sin Gon Kim, Kyung Ju Lee
  Endocrinology and Metabolism.2021; 36(5): 988.     CrossRef
• Symptom Clusters and Quality of Life in Patients with Type 2 Diabetes Mellitus
  Su-Yeon Hong, Yang-Sook Yoo
  Korean Journal of Adult Nursing.2021; 33(5): 498.     CrossRef
• Long-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study
  Eu Jeong Ku, Dong-Hwa Lee, Hyun Jeong Jeon, Tae Keun Oh
  Diabetes Research and Clinical Practice.2021; 182: 109123.     CrossRef
• Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes
  Jaekyung Bae, Ji-Hyung Yoon, Jung-Hee Lee, Jong-Ho Nam, Chan-Hee Lee, Jang-Won Son, Ung Kim, Jong-Seon Park, Dong-Gu Shin
  The Korean Journal of Internal Medicine.2021; 36(6): 1365.     CrossRef
• Role of Leptin with hypothyroidism in Iraqi diabetic type 2 patients
  Sulaiman M. Hasan
  Bionatura.2021; 6(4): 2274.     CrossRef
• Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data
  Hong Ki Min, Se Hee Kim, Jong Han Choi, Kyomin Choi, Hae-Rim Kim, Sang-Heon Lee
  World Journal of Clinical Cases.2021; 9(33): 10198.     CrossRef
• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Comparisons of Neuropsychological Characteristics of Elderly Subjects With Versus Without History of Agent Orange Exposure
  Seunggyu Han, Jinhee Choi, Hyung Seok So, Hayun Choi, Hong Jin Jeon, Jinseob Kim, Kiwon Kim
  Journal of Korean Neuropsychiatric Association.2021; 60(4): 346.     CrossRef
• Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
  Hae Kyung Kim, Minyoung Lee, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
  Min Ho Kim, Hyung Jung Oh, Soon Hyo Kwon, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Hyoungnae Kim, Dong-Ryeol Ryu
  Kidney Research and Clinical Practice.2021; 40(4): 660.     CrossRef
• Sleep Duration and Its Associations with Mortality and Quality of Life in Chronic Obstructive Pulmonary Disease: Results from the 2007–2015 KNAHNES
  So Jeong Kim, Nakwon Kwak, Sun Mi Choi, Jinwoo Lee, Young Sik Park, Chang-Hoon Lee, Sang-Min Lee, Chul-Gyu Yoo, Jaeyoung Cho
  Respiration.2021; 100(11): 1043.     CrossRef
• Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
  Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
  Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
• Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design
  Sera Lee, Miyoung Ock, Hun‐Sung Kim, Hyunah Kim
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2020; 40(9): 902.     CrossRef
• Diabetic kidney disease: seven questions
  Dong Ho Yang, So-Young Lee
  Journal of the Korean Medical Association.2020; 63(1): 6.     CrossRef
• Diabetes and Metabolism Journal in 2020: Good to Great
  In-Kyung Jeong
  Diabetes & Metabolism Journal.2020; 44(1): 1.     CrossRef
• The Use of Mobile Personal Health Records for Hemoglobin A1c Regulation in Patients With Diabetes: Retrospective Observational Study
  Dongjin Seo, Yu Rang Park, Yura Lee, Ji Young Kim, Joong-Yeol Park, Jae-Ho Lee
  Journal of Medical Internet Research.2020; 22(6): e15372.     CrossRef
• Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy
  Kyung Ae Lee, Tae Sun Park, Heung Yong Jin
  Endocrine.2020; 70(3): 465.     CrossRef
• An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men
  Seol Ju Moon, Kyung-Sang Yu, Min-Gul Kim
  Clinical Therapeutics.2020; 42(6): 1047.     CrossRef
• The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
  Mi Kyung Kim, Jae-Han Jeon, Sung-Woo Kim, Jun Sung Moon, Nan Hee Cho, Eugene Han, Ji Hong You, Ji Yeon Lee, Miri Hyun, Jae Seok Park, Yong Shik Kwon, Yeon-Kyung Choi, Ki Tae Kwon, Shin Yup Lee, Eon Ju Jeon, Jin-Woo Kim, Hyo-Lim Hong, Hyun Hee Kwon, Chi Yo
  Diabetes & Metabolism Journal.2020; 44(4): 602.     CrossRef
• The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
  Seung Min Chung, Yin Young Lee, Eunyeong Ha, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee, Jian Hur, Kyung Soo Hong, Jong Geol Jang, Hyun Jung Jin, Eun Young Choi, Kyeong-Cheol Shin, Jin Hong Chung, Kwan Ho Lee, June Hong Ahn, Jun Sung Moon
  Diabetes & Metabolism Journal.2020; 44(3): 405.     CrossRef
• A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea
  Mee-Kyoung Kim, Kyungdo Han, Jae-Hyoung Cho, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
  Diabetes Research and Clinical Practice.2020; 163: 108157.     CrossRef
• Effects of Cardiovascular Risk Factor Variability on Health Outcomes
  Seung-Hwan Lee, Mee Kyoung Kim, Eun-Jung Rhee
  Endocrinology and Metabolism.2020; 35(2): 217.     CrossRef
• Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
  Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon
  Diabetes & Metabolism Journal.2020; 44(4): 489.     CrossRef
• Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
  Kyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, Miyeun Han, Dong Won Lee, Hyuk-Sang Kwon
  Diabetes & Metabolism Journal.2020; 44(1): 3.     CrossRef
• Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
  Eun-Jung Rhee
  Endocrinology and Metabolism.2020; 35(1): 85.     CrossRef
• Using adult stem cells to monitor endothelial dysfunction in diabetes mellitus
  Rohit Jain, Hassan Awal, Sabyasachi Sen
  Journal of Diabetes and its Complications.2020; 34(7): 107588.     CrossRef
• Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction
  Nam Hoon Kim, Sin Gon Kim
  Diabetes & Metabolism Journal.2020; 44(2): 213.     CrossRef
• Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
  Kyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, Miyeun Han, Dong Won Lee, Hyuk-Sang Kwon
  Kidney Research and Clinical Practice.2020; 39(1): 32.     CrossRef
• Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control
  Min Jung Kim, Eun Young Lee, Young-Hye You, Hae Kyung Yang, Kun-Ho Yoon, Ji-Won Kim
  Stem Cell Research.2020; 48: 101958.     CrossRef
• Glucose-Lowering Effect of Home-Delivered Therapeutic Meals in Patients with Type 2 Diabetes
  Jong Han Choi, Se Hee Min, Kyeong Hye Lim, Uoon Jeong Shin, Min-Seon Kim
  The Journal of Korean Diabetes.2020; 21(1): 46.     CrossRef
• Subclinical thyroid dysfunction in the first trimester of pregnancy: ‘Disease’ versus physiological (pulsatile) variation in TSH concentrations
  Krzysztof C. Lewandowski, Karolina Garnysz, Wojciech Horzelski, Joanna Kawalec, Karolina Budzen, Mariusz Grzesiak, Andrzej Lewinski
  Clinical Endocrinology.2020; 93(6): 739.     CrossRef
• Usefulness of carotid ultrasonography and treatment of carotid disease
  Seung Min Kim, Yeon Jung Kim, Keonwoo Kim, Bum Joon Kim
  Journal of the Korean Medical Association.2020; 63(6): 342.     CrossRef
• Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
  Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
  International Journal of Endocrinology.2020; 2020: 1.     CrossRef
• Prepregnancy smoking and the risk of gestational diabetes requiring insulin therapy
  Mee Kyoung Kim, Kyungdo Han, Sang Youn You, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
  Scientific Reports.2020;[Epub]     CrossRef
• Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
  Wayne Huey-Herng Sheu, Siew Pheng Chan, Bien J. Matawaran, Chaicharn Deerochanawong, Ambrish Mithal, Juliana Chan, Ketut Suastika, Chin Meng Khoo, Huu Man Nguyen, Ji Linong, Andrea Luk, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2020; 44(1): 11.     CrossRef
• Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405–13)
  Seung Min Chung, June Hong Ahn, Jun Sung Moon
  Diabetes & Metabolism Journal.2020; 44(4): 625.     CrossRef
• Effect of roux-en Y gastric bypass surgery on patients with type 2 diabetes mellitus
  Ke-Yan Chen, Ying-Li Liu, Jin-Cai Shang, De-Wang Su, Rong-Rong Yao, De-Zhi Ke, Hao Tian
  Medicine.2020; 99(23): e20382.     CrossRef
• Comparison and Implication of the Contemporary Blood Pressure Guidelines on Korean Population
  So Mi Jemma Cho, Hokyou Lee, Hyeon Chang Kim
  Korean Circulation Journal.2020; 50(6): 485.     CrossRef
• Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)
  Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie B. Park, Kyu J. Ahn, Cheol‐Young Park, Su K. Kwon, Hye S. Kim, Seok W. Park, Sin G. Kim, Min K. Moon, Eun S. Kim, Choon H. Chung, Kang S. Park, Mikyung Kim, Dong J. Chung, Chang B. Lee, Tae H. Kim, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2020; 22(9): 1527.     CrossRef
• Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
  Kyung-Soo Kim, Byung-Wan Lee
  Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef
• Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
  Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
  Endocrinology and Metabolism.2020; 35(3): 636.     CrossRef
• Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study
  Min Cheol Chang, Jong-Moon Hwang, Jae-Han Jeon, Sang Gyu Kwak, Donghwi Park, Jun Sung Moon
  Endocrinology and Metabolism.2020; 35(3): 595.     CrossRef
• Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
  Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon
  Kidney Research and Clinical Practice.2020; 39(3): 269.     CrossRef
• Dynamic changes in nocturnal blood glucose levels are associated with sleep-related features in patients with obstructive sleep apnea
  Jung-Ick Byun, Kwang Su Cha, Ji Eun Jun, Tae-Joon Kim, Ki-Young Jung, In-Kyung Jeong, Won Chul Shin
  Scientific Reports.2020;[Epub]     CrossRef

• Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus

  
  Eugene Han, Minyoung Lee, Yong-ho Lee, Hye Soon Kim, Byung-wan Lee, Bong-Soo Cha, Eun Seok Kang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4113.     CrossRef
• A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study)
  Eun Heui Kim, Sang Soo Kim, Dong Jun Kim, Young Sik Choi, Chang Won Lee, Bon Jeong Ku, Kwang Soo Cha, Kee Ho Song, Dae Kyeong Kim, In Joo Kim
  Scientific Reports.2020;[Epub]     CrossRef
• Effect of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Weight on Emergency Hospitalization and 30‐Day Mortality in the General Population
  Seung‐Hwan Lee, Kyungdo Han, Hyuk‐Sang Kwon, Kun‐Ho Yoon, Mee Kyoung Kim
  Journal of the American Heart Association.2020;[Epub]     CrossRef
• Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management
  Aisling Smyth, Mark Jenkins, Melissa Dunham, Yvonne Kutzer, Shahrad Taheri, Lisa Whitehead
  Diabetes Research and Clinical Practice.2020; 170: 108532.     CrossRef
• The risk factors for treatment-related mortality within first three months after kidney transplantation
  Ye Na Kim, Do Hyoung Kim, Ho Sik Shin, Sangjin Lee, Nuri Lee, Min-Jeong Park, Wonkeun Song, Seri Jeong, Robert Jeenchen Chen
  PLOS ONE.2020; 15(12): e0243586.     CrossRef
• The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study
  Sangmo Hong, Kyungdo Han, Cheol-Young Park
  BMC Medicine.2020;[Epub]     CrossRef
• The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data
  Byoungjin Park, Yong-Jae Lee, Hye Sun Lee, Dong-Hyuk Jung
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Increased Age of Death and Change in Causes of Death Among Persons With Diabetes Mellitus From the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
  SSRN Electronic Journal .2020;[Epub]     CrossRef
• Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
  Jun Sung Moon
  Diabetes & Metabolism Journal.2019; 43(6): 911.     CrossRef
• Differences in prevalence of hypertension subtypes according to the 2018 Korean Society of Hypertension and 2017 American College of Cardiology/American Heart Association guidelines: The Korean National Health and Nutrition Examination Survey, 2007–2017 (
  So Mi Jemma Cho, Hokyou Lee, Hyeon Chang Kim
  Clinical Hypertension.2019;[Epub]     CrossRef
• Adult Stem Cells: Beyond Regenerative Tool, More as a Bio-Marker in Obesity and Diabetes
  Sabyasachi Sen
  Diabetes & Metabolism Journal.2019; 43(6): 744.     CrossRef
• Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease
  Mee Kyoung Kim, Kyungdo Han, Han Na Joung, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Management of Cardiovascular Risk Factors in Elderly Diabetes Mellitus Patients
  Sung Hoon Yu
  The Journal of Korean Diabetes.2019; 20(4): 233.     CrossRef
• Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2019;43:582–9)
  Tae Seo Sohn
  Diabetes & Metabolism Journal.2019; 43(6): 909.     CrossRef
• An Age of Sodium-Glucose Cotransporter-2 Inhibitor Priority: Are We Ready?
  Ji A Seo
  Diabetes & Metabolism Journal.2019; 43(5): 578.     CrossRef
• Association between Diabetes and the Use of Removable Dental Prostheses among the Korean Population
  Jae-Hyun Lee, Jung-Suk Han, Kyungdo Han, Su-Young Lee
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Metabolic Surgery and Diabetes Mellitus: Its Effects and Side Effects
  Mee Kyoung Kim
  The Journal of Korean Diabetes.2019; 20(4): 205.     CrossRef

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Citations

Citations to this article as recorded by  

• Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
  Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
  Advances in Therapy.2024; 41(5): 1967.     CrossRef
• Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
  Youngsook Kim, Ji Hye Huh, Minyoung Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
  Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
  Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
• Effects of an actual insulin injection demonstration on insulin acceptance among patients with T2DM: a pragmatic randomized controlled trial
  Atthayaporn Choomai, Apichai Wattanapisit, Orathai Tiangtam
  Romanian Journal of Internal Medicine.2021; 59(2): 151.     CrossRef
• Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
  Han Na Jang, Ye Seul Yang, Seong Ok Lee, Tae Jung Oh, Bo Kyung Koo, Hye Seung Jung
  Endocrinology and Metabolism.2019; 34(4): 382.     CrossRef
• Capacity and confidence building for general practitioners on optimum insulin use
  Sanjay Kalra, Prasun Deb, KalyanK Gangopadhyay, Sunil Gupta, Abhay Ahluwalia
  Journal of Family Medicine and Primary Care.2019; 8(10): 3096.     CrossRef
• Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients
  Eun Chong Shin
  The Journal of Korean Diabetes.2018; 19(2): 101.     CrossRef
• Summary of Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee
  The Journal of Korean Diabetes.2018; 19(1): 31.     CrossRef
• New anti-diabetic agents
  Doo-Man Kim
  Journal of the Korean Medical Association.2017; 60(12): 992.     CrossRef

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic agents (OHAs), general recommendations were not changed from those of the 2015 KDA guidelines. The Committee on Clinical Practice Guidelines of the KDA has extensively reviewed and discussed the results of meta-analyses and systematic reviews of effectiveness and safety of OHAs and many clinical trials on Korean patients with T2DM for the update of guidelines. All OHAs were effective when added to metformin or metformin and sulfonylurea, although the effects of each agent on body weight and hypoglycemia were different. Therefore, selection of a second agent as a metformin add-on therapy or third agent as a metformin and sulfonylurea add-on therapy should be based on the patient's clinical characteristics and the efficacy, side effects, mechanism of action, risk of hypoglycemia, effect on body weight, patient preference, and combined comorbidity. In this review, we address the results of meta-analyses and systematic reviews, comparing the effectiveness and safety among OHAs. It will help to choose the appropriate drug for an individual patient with T2DM.

Citations

Citations to this article as recorded by  

• Unveiling the potential of prodrug and drug-conjugate strategies in treatment of diabetes mellitus and its complications
  Neha V. Bhilare, Rushikesh Shedge, Prashant M. Tambe, Ajinkya More
  Medicinal Chemistry Research.2024; 33(3): 337.     CrossRef
• Simultaneous Estimation of Repaglinide and Voglibose in Newly Approved Fixed-Dose Combination by using UFLC: Application to ICH Q14 Concept and Comparative Method Greenness Assessment
  S.S. Panda, P.C. Rauta, V.S. Pulusu, S. Sahu, B.B. Dash
  Asian Journal of Chemistry.2023; 35(4): 887.     CrossRef
• Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
  Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
  International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
• The Gut Microbiome, Metformin, and Aging
  Sri Nitya Reddy Induri, Payalben Kansara, Scott C. Thomas, Fangxi Xu, Deepak Saxena, Xin Li
  Annual Review of Pharmacology and Toxicology.2022; 62(1): 85.     CrossRef
• Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial
  Wajiha Mahjabeen, Dilshad Ahmed Khan, Shakil Ahmed Mirza
  Complementary Therapies in Medicine.2022; 66: 102819.     CrossRef
• Letrozole: Pharmacology, toxicity and potential therapeutic effects
  Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Dhanushya Nagarajan, Vibhaa K K, Anagha V, Joshua Paul P, Tharani Priya T, Rituraj Chakraborty, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan
  Life Sciences.2022; 310: 121074.     CrossRef
• Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
  Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
  Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
• Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non‐interventional comparative study
  Sirajudeen Shaik Alavudeen, Sultan M. Alshahrani, Easwaran Vigneshwaran, Noohu Abdulla Khan, Javid I. Mir, Abubakr T. M. Hussein
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
  Antonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, Maria Fesatidou, Ioannis Nicolaou, Athina Geronikaki
  European Journal of Medicinal Chemistry.2020; 207: 112742.     CrossRef
• Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
  Hannah Seok, Tae Seo Sohn
  Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
• A Survey of the Structures of US FDA Approved Combination Drugs
  Pradipta Das, Michael D. Delost, Munaum H. Qureshi, David T. Smith, Jon T. Njardarson
  Journal of Medicinal Chemistry.2019; 62(9): 4265.     CrossRef
• Experimental design methodology for optimization and robustness determination in ion pair RP-HPLC method development: Application for the simultaneous determination of metformin hydrochloride, alogliptin benzoate and repaglinide in tablets
  Marianne A. Mahrouse, Nesrine T. Lamie
  Microchemical Journal.2019; 147: 691.     CrossRef
• The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
  Da Young Lee, Ji Hee Yu, Sanghyun Park, Kyungdo Han, Nam Hoon Kim, Hye Jin Yoo, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim, Ji A. Seo
  Scientific Reports.2018;[Epub]     CrossRef
• Effect of Lifestyle Modification and Oral Anti-Diabetic Drugs on Metabolic Parameters in Recently Diagnosed Patientswith Uncomplicated Type 2 Diabetes Mellitus in Eastern India
  Nikhilesh Pradhan, Sidhartha Das, Anoj Kumar Baliarsinha, Ashirbad Parhi, Bijan Patnaik, Pramod Kumar Rout
  Journal of Diabetes Mellitus.2018; 08(02): 9.     CrossRef
• Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program
  Ja Young Jeon, Soo Jin Lee, Sieun Lee, Soo Jin Kim, Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Moonsuk Nam, Sei Hyun Baik, Yongsoo Park, Kwan‐Woo Lee
  Journal of Diabetes Investigation.2018; 9(5): 1144.     CrossRef

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.

Citations

Citations to this article as recorded by  

• Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms
  Pranay Wal, Jyotsana Dwivedi, Ankita Wal, Shivangi Kushwaha
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
  Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
  Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
• Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors
  Amani Toumi, Sarra Boudriga, Khaled Hamden, Mansour Sobeh, Mohammed Cheurfa, Moheddine Askri, Michael Knorr, Carsten Strohmann, Lukas Brieger
  Bioorganic Chemistry.2021; 106: 104507.     CrossRef
• Clinical Impact of Combination Therapy in Diabetic Neuropathy and Nephropathy
  Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar
  Research Journal of Pharmacy and Technology.2021; : 3471.     CrossRef
• Type II diabetes mellitus: a review on recent drug based therapeutics
  Santwana Padhi, Amit Kumar Nayak, Anindita Behera
  Biomedicine & Pharmacotherapy.2020; 131: 110708.     CrossRef
• Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
  Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
  Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
• Metabolomics approach to identify the active substances influencing the antidiabetic activity of Lagerstroemia species
  Mun-Ock Kim, Su Ui Lee, Heung Joo Yuk, Hyun-Jae Jang, Jae-Won Lee, Eun-Bin Kwon, Jin-Hyub Paik, SangHo Choi, Adek Nizar, Tran The Bach, Kongmany Sydara, Hang Jin, So-Yeun Woo, Sei-Ryang Oh, Hyung Won Ryu
  Journal of Functional Foods.2020; 64: 103684.     CrossRef
• Cardiometabolic diseases and active aging - polypharmacy in control
  Adriana Nancy Medeiros dos Santos, Dulcineia Rebecca Cappelletti Nogueira, Beatriz Aparecida Ozello Gutierrez, Rosa Yuka Sato Chubaci, Caroline Ribeiro de Borja Oliveira
  Revista Brasileira de Enfermagem.2020;[Epub]     CrossRef
• Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from Termitornyces albuminosus via Regulation of NF-κB Signaling in db/db Mice
  Chang Yang, Qi Feng, Huan Liao, Xinlei Yu, Yang Liu, Di Wang
  International Journal of Molecular Sciences.2019; 20(20): 5205.     CrossRef
• Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes
  Min Joo Kim, Mi Na Kim, Se Hee Min, Dong-Sik Ham, Ji-Won Kim, Kun-Ho Yoon, Kyong Soo Park, Hye Seung Jung
  Metabolism.2019; 97: 87.     CrossRef
• A randomized, open‐label, multicentre, parallel‐controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti
  Lixin Guo, Li Chen, Baocheng Chang, Liyong Yang, Yu Liu, Bo Feng
  Diabetes, Obesity and Metabolism.2018; 20(12): 2740.     CrossRef
• Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
  Sang Youl Rhee
  The Journal of Korean Diabetes.2018; 19(1): 15.     CrossRef

In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last update in 2015, many results from clinical trials have been introduced, and domestic data from studies performed in Korean patients with T2DM have been published. Recently, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations. Additionally, new data from clinical trials using dipeptidyl peptidase 4 inhibitors and thiazolidinediones in Korean patients with T2DM were added. Following a systematic review and assessment of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the use of antihyperglycemic agents and revised the treatment algorithm for Korean adult patients with T2DM.

Citations

Citations to this article as recorded by  

• Comparative Study on Efficacy of Empagliflozin Versus Sitagliptin, as an Add-on Therapy to Metformin in Type 2 Diabetic Patients
  Harsh Salankar, Sonali Rode, C. Arjun, Rajeeta Joseph, Gourav B. Deshmane, Radhika P. Vijayan
  Journal of Pharmacy and Bioallied Sciences.2024; 16(Suppl 1): S335.     CrossRef
• Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
  Young-Hwan Park, Minji Sohn, So Yeon Lee, Soo Lim
  Diabetes & Metabolism Journal.2024; 48(2): 253.     CrossRef
• Association of preoperative blood glucose level with delirium after non-cardiac surgery in diabetic patients
  Soo Jung Park, Ah Ran Oh, Jong-Hwan Lee, Kwangmo Yang, Jungchan Park
  Korean Journal of Anesthesiology.2024; 77(2): 226.     CrossRef
• Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
  R. Pelluri, S. Kongara, V. R. Nagasubramanian, S. Mahadevan, J. Chimakurthy
  Journal of Endocrinological Investigation.2023; 46(5): 855.     CrossRef
• Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
  Hyeong Kyu Park, Kyoung‐Ah Kim, Kyung‐Wan Min, Tae‐Seo Sohn, In Kyung Jeong, Chul Woo Ahn, Nan‐Hee Kim, Ie Byung Park, Ho Chan Cho, Choon Hee Chung, Sung Hee Choi, Kang Seo Park, Seoung‐Oh Yang, Kwan Woo Lee
  Diabetes, Obesity and Metabolism.2023; 25(9): 2743.     CrossRef
• Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection
  Jong Chul Won
  The Journal of Korean Diabetes.2023; 24(2): 59.     CrossRef
• A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation
  Mazhar Ahmed, Asjad Saeed, Muhammad Zarar Khan, Sana Z Javaid, Farhan Aslam, Savida Ilyas Dar
  Cureus.2023;[Epub]     CrossRef
• Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio
  Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2023; 47(6): 808.     CrossRef
• Efficacy and Safety of Mulberry Twig Alkaloids Tablet for Treatment of Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study
  Ling Qu, Xiao-chun Liang, Guo-qing Tian, Gai-li Zhang, Qun-li Wu, Xiu-mei Huang, Ya-zhong Cui, Yu-ling Liu, Zhu-fang Shen, Guo-qing Ma, Hao Lu, Yi Li, Hong Jiang, Xi-yan Yang, Guang-de Zhang, Chen-hua Yang
  Chinese Journal of Integrative Medicine.2022; 28(4): 304.     CrossRef
• Risk for Imbalanced Blood Glucose Pattern: Construct Analysis and Nursing Diagnosis Proposal
  Rafael Oliveira Pitta Lopes, Jéssica de Castro Santos, Hudson Carmo de Oliveira, Juliana Faria Campos, Cândida Caniçali Primo, Camila Takáo Lopes, Marcos Antônio Gomes Brandão
  Clinical Nursing Research.2022; 31(7): 1241.     CrossRef
• Long‐term clinical outcomes of oral antidiabetic drugs as fixed‐dose combinations: A nationwide retrospective cohort study
  Sang‐Jun Cho, In‐Sun Oh, Han Eol Jeong, Young Min Cho, Yul Hwangbo, Oriana Hoi Yun Yu, Ju‐Young Shin
  Diabetes, Obesity and Metabolism.2022; 24(10): 2051.     CrossRef
• Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
  Muaz Mubashir, Mazhar Ahmed, Hassan Atique, Ahmed Wassan, Mehdi Naqvi, Muneeb Ullah
  Cureus.2022;[Epub]     CrossRef
• The Mediating Effect of Acceptance Action in the Relationship between Diabetes Distress and Self-stigma among Old Adults with Diabetes in South Korea
  Hyesun Kim, Kawoun Seo
  Journal of Korean Academy of Community Health Nursing.2022; 33(4): 446.     CrossRef
• Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
  Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
  Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
• Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
  Linong Ji, Jianhua Ma, Weiping Lu, Jingdong Liu, Jiao’e Zeng, Jialin Yang, Wei Li, Xiuzhen Zhang, Xinhua Xiao, Gen Takayanagi, Yi Wang
  Journal of Diabetes Investigation.2021; 12(4): 537.     CrossRef
• Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
  Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
  Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
• Blood glucose levels and bodyweight change after dapagliflozin administration
  Hyunah Kim, Seung‐Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Hun‐Sung Kim
  Journal of Diabetes Investigation.2021; 12(9): 1594.     CrossRef
• Effects of liraglutide combined with metformin and Diamicron on glucose–lipid metabolism and islet β-cell function in elderly patients with type 2 diabetes mellitus
  Chunzhi Zhao, Xing Li, Jianhua Ma, Zhengtai Zhu, Hua Li, Fangli Lou, Yuefang Zhai, Hui Chen, Shujun Xiao, Qinhui Peng, Huilian Hua, Qing Zhang, Fangyong Lou
  All Life.2021; 14(1): 333.     CrossRef
• Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
  Ling Qu, Xiaochun Liang, Guoqing Tian, Gaili Zhang, Qunli Wu, Xiumei Huang, Yazhong Cui, Yuling Liu, Zhufang Shen, Changqing Xiao, Yingfen Qin, Heng Miao, Yongyan Zhang, Ziling Li, Shandong Ye, Xuezhi Zhang, Jing Yang, Guiwen Cao, Yi Li, Gangyi Yang, Ji H
  Diabetes Care.2021; 44(6): 1324.     CrossRef
• Clinical Impact of Combination Therapy in Diabetic Neuropathy and Nephropathy
  Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar
  Research Journal of Pharmacy and Technology.2021; : 3471.     CrossRef
• Effect of Voluntary Participation on Mobile Health Care in Diabetes Management: Randomized Controlled Open-Label Trial
  Da Young Lee, Seung-Hyun Yoo, Kyong Pil Min, Cheol-Young Park
  JMIR mHealth and uHealth.2020; 8(9): e19153.     CrossRef
• Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
  Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
  Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
• Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
  Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim
  Diabetes & Metabolism Journal.2020; 44(1): 67.     CrossRef
• Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
  Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
  International Journal of Endocrinology.2020; 2020: 1.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
  Jae Hyun Bae, Hyung Jin Choi, Kang Ik Kevin Cho, Lee Kyung Kim, Jun Soo Kwon, Young Min Cho
  Diabetes & Metabolism Journal.2020; 44(2): 248.     CrossRef

• Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects

  
  Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
  Drug Design, Development and Therapy.2020; Volume 14: 5179.     CrossRef
• Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
  Yun Kyung Cho, Jiwoo Lee, Yu Mi Kang, Jee Hee Yoo, Joong-Yeol Park, Chang Hee Jung, Woo Je Lee, Tatsuo Shimosawa
  PLOS ONE.2019; 14(8): e0220667.     CrossRef
• Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial
  Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, Taekeun Oh, Eun Sook Kim, Nan‐Hee Kim, Kyung Mook Choi, Sung‐Rae Kim, JiYoung You, Se‐Jin Kim, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2019; 21(3): 631.     CrossRef
• Pharmacotherapy of Diabetes Focused on Stroke
  Young-Sang Lyu, Jin-Hwa Kim, Sang-Yong Kim
  Journal of the Korean Neurological Association.2019; 37(3): 235.     CrossRef
• Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
  Hannah Seok, Tae Seo Sohn
  Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
• Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors
  Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang
  Diabetes Care.2019; 42(11): 2057.     CrossRef
• Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
  Tae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu
  Diabetes & Metabolism Journal.2019; 43(3): 276.     CrossRef
• 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
  Mee Kyoung Kim, Seung-Hyun Ko, Bo-Yeon Kim, Eun Seok Kang, Junghyun Noh, Soo-Kyung Kim, Seok-O Park, Kyu Yeon Hur, Suk Chon, Min Kyong Moon, Nan-Hee Kim, Sang Yong Kim, Sang Youl Rhee, Kang-Woo Lee, Jae Hyeon Kim, Eun-Jung Rhee, SungWan Chun, Sung Hoon Yu
  Diabetes & Metabolism Journal.2019; 43(4): 398.     CrossRef
• Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
  Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
  Endocrinology and Metabolism.2019; 34(4): 349.     CrossRef
• Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
  Sang Youl Rhee
  The Journal of Korean Diabetes.2018; 19(1): 15.     CrossRef
• Glucose Control in Intensive Care Unit Patients: Recent Updates
  Sang Youl Rhee
  Journal of Neurocritical Care.2018; 11(2): 81.     CrossRef
• Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients
  Eun Chong Shin
  The Journal of Korean Diabetes.2018; 19(2): 101.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
  Hyun Jin Kim
  The Journal of Korean Diabetes.2018; 19(1): 35.     CrossRef
• Fifty Years of Compassionate Care and Harmonious Collaboration of the Korean Diabetes Association: The 50th Anniversary of Korean Diabetes Association
  Jong Chul Won, Eun-Jung Rhee, Hyung Joon Yoo
  Diabetes & Metabolism Journal.2018; 42(6): 475.     CrossRef
• Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
  Kyung‐Ah Han, Suk Chon, Choon Hee Chung, Soo Lim, Kwan‐Woo Lee, SeiHyun Baik, Chang Hee Jung, Dong‐Sun Kim, Kyong Soo Park, Kun‐Ho Yoon, In‐Kyu Lee, Bong‐Soo Cha, Taishi Sakatani, Sumi Park, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2018; 20(10): 2408.     CrossRef
• Monotherapy in Patients with Type 2 Diabetes Mellitus
  Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 349.     CrossRef
• Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  The Korean Journal of Internal Medicine.2017; 32(6): 967.     CrossRef
• New anti-diabetic agents
  Doo-Man Kim
  Journal of the Korean Medical Association.2017; 60(12): 992.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
  Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi
  Diabetes & Metabolism Journal.2017; 41(6): 423.     CrossRef
• Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  Diabetes & Metabolism Journal.2017; 41(5): 367.     CrossRef